iShares U.S. Pharmaceuticals ETF closed at $110.25 on Nov 12, down 0.75%, 0.7% below its 52-week closing high. Volume of 199.3K shares was 0.69× its 20-day average (below normal).
Split-adjusted performance: +10.8% over one month, +23.1% over six months, +38.2% over one year.
Short interest was 429.1K shares at the Oct 30 settlement, up 61.1% from the prior report (1.7 days to cover).
Does iShares U.S. Pharmaceuticals ETF pay a dividend?
Yes. The latest regular dividend was $0.2789 per share (ex-date Sep 15), an annualised yield of 1.01%.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology